Industry News
Pharmaceutical Industry News
Antibody Drug to Protect the Vulnerable From Covid Goes Unused
The treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to prescribe it.
FDA Rejects India-Made Bharat Biotech Vaccine For Those Under 18
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for any age groups.
Rapper Chuck D, SU2C team with PatientPoint to bring colon cancer screening message to the exam room
Rapper Chuck D, SU2C team with PatientPoint to bring colon cancer screening message to the exam room nmissakian Fri, 03/04/2022 - 16:51
Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassment
Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassment kdunleavy Fri, 03/04/2022 - 13:43
Evolus’ has something to smile about as neurotoxin Jeuveau’s 2021 sales swell 76%
Evolus' has something to smile about as neurotoxin Jeuveau's 2021 sales swell 76% fkansteiner Fri, 03/04/2022 - 11:12
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first U.S. drug launch
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first U.S. drug launch aliu Fri, 03/04/2022 - 11:10
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first US drug launch
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first US drug launch aliu Fri, 03/04/2022 - 11:10
GlaxoSmtihKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million
GlaxoSmtihKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million kdunleavy Fri, 03/04/2022 - 09:56
GlaxoSmithKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million
GlaxoSmithKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million kdunleavy Fri, 03/04/2022 - 09:56
Amgen’s Xgeva campaign features real patients talking about their lives after diagnosis
Amgen's Xgeva campaign features real patients talking about their lives after diagnosis sharon.coey Fri, 03/04/2022 - 09:36
Amgen’s Xgeva campaign features real cancer patients talking about their lives after diagnosis
Amgen's Xgeva campaign features real cancer patients talking about their lives after diagnosis sharon.coey Fri, 03/04/2022 - 09:36
Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears
Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears fkansteiner Fri, 03/04/2022 - 09:07
Eli Lilly extends winning streak as it keeps the TV ad spend throne holding off Regeneron’s Dupixent
Eli Lilly extends winning streak as it keeps the TV ad spend throne holding off Regeneron's Dupixent badams Fri, 03/04/2022 - 07:48
Eli Lilly extends winning streak as it keeps the TV ad spend throne, holding off Sanofi and Regeneron’s Dupixent
Eli Lilly extends winning streak as it keeps the TV ad spend throne, holding off Sanofi and Regeneron's Dupixent badams Fri, 03/04/2022 - 07:48
Fierce Pharma Asia—J&J, Legend’s CAR-T nod; Biocon’s $3.3B Viatris biosimilar buy; Sanofi-Adagene tie-up
Fierce Pharma Asia—J&J, Legend's CAR-T nod; Biocon's $3.3B Viatris biosimilar buy; Sanofi-Adagene tie-up aliu Fri, 03/04/2022 - 05:16
On heels of Super Bowl ad, Hologic inks title sponsorship deal with Women’s Tennis Association Tour
On heels of Super Bowl ad, Hologic inks title sponsorship deal with Women's Tennis Association Tour nmissakian Thu, 03/03/2022 - 18:05
Billionaire Sackler family enters $6B opioid deal with support from holdout states
Billionaire Sackler family enters $6B opioid deal with support from holdout states esagonowsky Thu, 03/03/2022 - 14:46
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits kdunleavy Thu, 03/03/2022 - 14:41
Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktail
Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktail fkansteiner Thu, 03/03/2022 - 13:27
Biogen starts layoff round as the Aduhelm maker struggles with Alzheimer’s rollout
Biogen starts layoff round as the Aduhelm maker struggles with Alzheimer’s rollout aliu Thu, 03/03/2022 - 11:22